MedTrace Logo

Treatment for Adductor Spasmodic Dysphonia by Type 2 Thyroplasty Using Titanium Bridges

NCT02528006 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2018-05-02

No results posted yet for this study

Summary

For adductor spasmodic dysphonia, there is a need for establishing a new therapy under the present circumstance where no standard therapy has been established yet and existing therapies fail to provide permanent effect. Evaluation of the efficacy of type 2 thyroplasty using titanium bridges will expand the therapeutic options available for adductor spasmodic dysphonia and establishment of a standard therapy.

Conditions

  • Adductor Spasmodic Dysphonia

Interventions

DEVICE

Type 2 Thyroplasty using Titanium Bridges

Sponsors & Collaborators

  • Hokkaido University Hospital

    collaborator OTHER

  • Yokohama City University Hospital

    collaborator UNKNOWN

  • Kyoto University

    collaborator OTHER

  • Kumamoto University

    lead OTHER

Principal Investigators

  • Tetsuji Sanuki, MD,PhD · Department of Otolaryngology,Kumamoto University

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-07-27
Primary Completion
2017-03-29
Completion
2017-03-29

Countries

  • Japan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02528006 on ClinicalTrials.gov